Enterprise Value
1.007B
Cash
88.6M
Avg Qtr Burn
-69.9M
Short % of Float
21.55%
Insider Ownership
2.29%
Institutional Own.
93.27%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
NARCAN (naloxone HCl) Details Opioid overdose | Approved Update | |
Vaxchora (pediatric) Details Cholera | Approved Quarterly sales | |
ACAM2000 Details Smallpox | Approved Quarterly sales | |
NARCAN (naloxone HCl) Details Opioid overdose | Approved Quarterly sales | |
CYFENDUS™ (AV7909 ) Details Anthrax | Approved Quarterly sales | |
Approved Quarterly sales | ||
Stabilized isoamyl nitrite (SIAN) Details Cyanide poisoning | Phase 1 Data readout | |
CHIKV VLP Details Chikungunya, Viral infection | Failed Discontinued | |
COVID-HIG Details COVID-19 | Failed Discontinued | |
FLU-IGIV Details Influenza | Failed Discontinued |